Product Name: Bortezomib CAS 179324-69-7
Chemical & Physical Properties:
Appearance : White to Off-White Powder
Assay : ≥99.0%
Melting point: 122-124℃
Refractive Index: 1.564
Solubility: Soluble in chloroform, dimethyl sulfoxide, ethanol and methanol.
Stability: Hygroscopic and Moisture Sensitive
Category: Amines, Metabolites & Impurities, Nucleotides, Bases & Related Reagents,
HS Code: 2934999090
Safety Phrases : S26-S36/37/39
RTECS NO: ED7771666
Storage:Hygroscopic, -20°C Freezer, Under Inert Atmosphere.
Application: 1.[(1R)-3-Methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic Acid is the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle found in the nucleus and cytosol of all eukaryotic cells. Targets the ubiquitin-proteasome pathway.
2. Bortezomib (PS-341) is a potent 20S proteasome inhibitor with a Ki of 0.6 nM.
Our factory manufacture’s Bortezomib CAS 179324-69-7, mature technology, stable output, quality assurance.
Inventory Status : In Stock.
We can provide CAS 179324-69-7 certificate of analysis( COA), N-[(1R)-1-(Dihydroxyboryl)-3-methylbutyl]-Nα-(pyrazin-2-ylcarbonyl)-L-phenylalaninamide MOA, Bortezomib ROS, MSDS and other support for you !
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.